Supriya Lifescience Inaugurates Rs 120-cr API Block

By By Rediff Money Desk, Mumbai
Dec 17, 2024 22:32
Supriya Lifescience has inaugurated a Rs 120-crore API production block in Ratnagiri, adding 335 kilolitre capacity to its operations. The unit expands Lote Parshuram capacity by over 55% to 932 KLPD.
Mumbai, Dec 17 (PTI) Supriya Lifescience on Tuesday inaugurated a Rs 120-crore multipurpose Active Pharmaceutical Ingredients (APIs) production block in Ratnagiri district's Lote Parshuram.

The unit adds a capacity of 335 kilolitre to the company's operations and will expand Lote Parshuram capacity by over 55 per cent to 932 KLPD, as per a statement.







*****
Niti Aayog's biennial conference on development ends

* The third biennial conference on development organised by the Niti Aayog at the RBI-promoted Indira Gandhi Institute of Development Research in association with the University of California Berkeley ended on Tuesday.

Delegates discussed aspects like infrastructure investment, climate change and urbanisation at the meet, Niti Aayog Vice-Chairman Suman Bery said.

The conference received support from the RBI and Sebi, both city-based regulators overseeing finance and capital markets, respectively, he said.






*****
DBS Bank launches offering to help customers pursue education abroad

* Singaporean lender DBS' local subsidiary DBS Bank India on Tuesday launched an offering to help customers pursue education abroad.

The solution christened DBS Study Abroad Total Assist entails educational loans, insurance covers and remittances, it said in a statement.






*****
Bank of Baroda launches phygital branches offering round-the-clock services

* State-run Bank of Baroda on Tuesday launched 'phygital branches' offering services round the clock for customers.

The branches integrate physical and digital banking services for customers with self-service kiosks, a video contact centre for non-financial services and universal service desks for in-person customer service, as per a statement.
Source: PTI
Read More On:
supriya lifescienceapiactive pharmaceutical ingredientsratnagirilote parshurampharmaceutical industryproductioncapacity expansioninvestment
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.

You May Like To Read

MORE NEWS

Nepal Allows Indian High-Value Notes After Ban

Nepal lifts decade-long ban on Indian high-value currency notes (Rs 200 & Rs 500) up to...

SBI Yono 2.0 Launched; Hiring 10,000 Staff

SBI launches Yono 2.0 & plans to hire 10,000 staff to help customers migrate to digital...

Ravi Ranjan Appointed SBI MD

Ravi Ranjan appointed Managing Director of State Bank of India (SBI). He succeeds Vinay...

KSH International IPO: Rs 213 Cr from Anchor...

KSH International raises Rs 213 cr from anchor investors ahead of its IPO. IPO opens...

NCDEX Gets Sebi Nod for Mutual Fund Platform

NCDEX receives Sebi approval for mutual fund platform, paving the way for equity...

WhatsApp Data Sharing: NCLAT Clarifies User...

NCLAT mandates user consent for WhatsApp data collection, including advertising. Learn...

Pajson Agro IPO Subscribed 6.59 Times on Day 3

Pajson Agro India''s Rs 74.4-cr SME IPO subscribed 6.59 times on final day. IPO...

Battery Storage Cost Falls: Rs 2.1/Unit, Power Min

Battery energy storage (BESS) cost drops to Rs 2.1/unit from Rs 10.18 in 2022-23....

India Rice Exports to US: No Dumping, Says...

Commerce Secretary clarifies India exports expensive basmati rice to the US, refuting...

360 One Raises Rs 2,300 Cr Realty Fund

360 One Asset raises Rs 2,300 crore real estate fund, deploying majority in projects....

Read More »

Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2025 Rediff.com